Research News
Catch up on the latest news from across the ataxia research world right here.
If you are interested in taking part in research, please click here for current opportunities. If you would like to find out about the research we are currently funding, please click here.
For other enquiries, or if you can’t find information on the type of ataxia you have, please contact our Helpline by emailing help@ataxia.org.uk or calling 0800 995 6037 (opening hours Monday-Thursday 10.30am-2.30pm).
![Omav approved header-Recovered Omav approved header-Recovered](https://www.ataxia.org.uk/wp-content/uploads/2023/03/Omav-approved-header-Recovered.png)
FDA approves Omav
Sign up to a dedicated newsletter and receive the latest news about Reata's SKYCLARYS (Omav) treatment for adults with Friedreich’s ataxia.
Ataxia UK hosts an educational webinar on the UK medicines approval process
Ataxia UK news, Cerebellar ataxia, Cerebellar ataxia pharma news, DRPLA, Friedreich's ataxia, Friedreich's ataxia pharma news, Latest News, Research News, SCAs, spastic ataxias, ataxia pharma, ataxia research, Ataxia UK Webinar, Cerebellar Ataxias, Friedreich's ataxia, Medicines Approvals0In conversation with Dr. Federico Herrera, Group Leader of the Cell Structure and Dynamics (CSD) Lab from the Biosystems and Integrative Sciences Institute (BioISI) at the Faculty of Sciences of the University of Lisbon (Ciências ULisboa).
Cerebellar ataxia, Research News, spastic ataxias, ataxia research, Ataxia Research News, Spastic Ataxia Type-8, Spastic Ataxias0Alterity Therapeutics presents data on the potential of ATH434 to treat FA
Cerebellar ataxia, Cerebellar ataxia pharma news, Friedreich's ataxia, Friedreich's ataxia pharma news, Research News, Alterity Therapeutics, ataxia research, Ataxia Research News, Friedreich's ataxia, Friedreich's ataxia pharma, MSA, MSA pharma0Lexeo announces positive results from their SUNRISE-FA trial of LX2006 for FA cardiomyopathy
Friedreich's ataxia, Friedreich's ataxia pharma news, Research News, Ataxia Gene Therapy, ataxia research, Ataxia Research News, Friedreich's ataxia, Friedreich's Ataxia Gene Therapy, Friedreich's ataxia news, Friedreich's ataxia pharma, Friedreich's ataxia research, gene therapy, Lexeo Therapeutics, LX20060Paper published on study of effectiveness of omaveloxolone for Friedreich’s ataxia using natural history study data
Friedreich's ataxia, Friedreich's ataxia pharma news, OMAV updates, Research News, Research News Archive, Friedreich's ataxia, Friedreich's ataxia pharma news, Friedreich's ataxia research, Natural History Study, Omaveloxolone, Skyclarys0Results of Ataxia UK-funded study assessing speech therapy in people with progressive ataxias
Cerebellar ataxia, Friedreich's ataxia, Research News, SCAs, ataxia speech therapy, cerebellar ataxia, cerebellar ataxia research, Friedreich's ataxia, Friedreich's ataxia research, Research news, SCA6, speech therapy, Strathclyde University0Reflections on the Ataxia UK Annual Conference 2023
Ataxia UK news, Cerebellar ataxia, Cerebellar ataxia pharma news, Friedreich's ataxia, Friedreich's ataxia pharma news, Latest News, OMAV updates, Past supporter events, Research News, SCAs, Virtual Activities, ataxia news, ataxia research, Ataxia UK annual conference, Ataxia UK annual conference 2023, Ataxia UK awards, Ataxia UK events, conferences, patient engagement0Subscribe To Our Newsletter
LATEST NEWS
- All
- Ataxia UK news
- Cerebellar ataxia
- Cerebellar ataxia pharma news
- DRPLA
- Friedreich's ataxia
- Friedreich's ataxia pharma news
- Latest News
- Research News
- SCAs
- spastic ataxias